Dr. Suprith Badarinath, MD

Dr. Badarinath practices at Cancer Specialists of North Florida in Jacksonville, Florida.

Dr. Badarinath's NPI, 1972508356, was assigned on June 14, 2005. Dr. Badarinath graduated from Sidney Kimmel Medical College in 1994. Dr. Badarinath holds Florida license ME 80727.

Dr. Badarinath's primary practice is Cancer Specialists of North Florida, at 7015 A C Skinner Pkwy, Jacksonville, FL 32256 in Duval County. The practice phone is (904) 363-2113.

Dr. Badarinath's primary practice is Cancer Specialists of North Florida in Jacksonville, Florida. Dr. Badarinath is also affiliated with Ascension St. Vincent's Riverside. The medical group on file is Cancer Specialists of North Florida. Dmand AI also links Dr. Badarinath to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Badarinath practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Badarinath's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Badarinath is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Badarinath's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Badarinath treats.

CMS data shows 61,915 Medicare services from Dr. Badarinath across 42 procedure codes in 2024, for 590 Medicare patients. Medicare paid $282,274 for them.

CMS counts 590 Medicare patients who saw Dr. Badarinath in 2024. The largest group is 75 to 84, with 232 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Badarinath's median patient age at 70, with 61% women.

In 2024, Dr. Badarinath wrote 817 Medicare Part D claims for 194 patients. 69% of them were for generic drugs. CMS names the drug for 640 of them, across 21 drugs with 11 or more claims each, at $821,378 in total drug cost. In 2023, CMS named 547 claims across 17 drugs.

Dr. Badarinath accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Badarinath, published from 2011 to 2017. The most frequent topics are Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols and Antibodies, Monoclonal. Dr. Badarinath has published most often in Clin Colorectal Cancer. Dr. Badarinath's most frequent co-authors are Lee S. Schwartzberg, MD, James Richard Berenson, MD and Bryan James Bienvenu, MD.

Dmand AI links Dr. Badarinath to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Breast Neoplasms, Multiple Myeloma and Neoplasm Metastasis.

CMS Open Payments shows 159 general payments to Dr. Badarinath from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. McKesson Specialty Care Distribution Corp. paid the most, $445.

Dmand AI lists 1 award for Dr. Badarinath, most recently CMS Stage 1 EHR in 2013.

Dr. Badarinath graduated from Sidney Kimmel Medical College in 1994. Dr. Badarinath is a member of ACP and ASCO.

Dr. Badarinath is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.